dr. hatchett. dr. hatchett: thank you. think the problem of biodefense is a tremendously far-reaching, and it stretches to all sectors of society, and all parts of government. the domain that we work in, public health and medical preparedness and response, i feel that we do have strong strategies. we do have strong collaborative measures. and we respond to the emergencies we are presented with. redd.ohnson: dr. dr. redd: there is a policy process, and that involves legislature, and the executive branch. this is a recommendation that need to be looked at very carefully. i certainly agree with them. many great things are going on between our respective agencies. i think those could all be bought together, for an advantage. i think that we are certainly taking to heart the blue-ribbon recommendations, and trying to implement as many of them as we can. i think there are strong strategies, strong coordinations. we discussed a few of them today, but there are many more. we are never going to be done. one of the things that strik

dr. hatchett. dr. hatchett: thank you. think the problem of biodefense is a tremendously far-reaching, and it stretches to all sectors of society, and all parts of government. the domain that we work in, public health and medical preparedness and response, i feel that we do have strong strategies. we do have strong collaborative measures. and we respond to the emergencies we are presented with. redd.ohnson: dr. dr. redd: there is a policy process, and that involves legislature, and the executive branch. this is a recommendation that need to be looked at very carefully. i certainly agree with them. many great things are going on between our respective agencies. i think those could all be bought together, for an advantage. i think that we are certainly taking to heart the blue-ribbon recommendations, and trying to implement as many of them as we can. i think there are strong strategies, strong coordinations. we discussed a few of them today, but there are many more. we are never going to be done. one of the things that strik

dr. hatchett and dr. redd, you can explain how the agencies make use of your research, kind of the sense of where our needs are and what you would like to see? >> sure, sir. thank you for that question. just to be clear, so, i am the acting director of the biomedical development as our name implies we work in the area of research and development. as we understand that term, it means when we're working on medical countermeasures, these are medical countermeasures that have reached the clinical stage of development and many of the problems relate to the clinical testing of the product, as well as to scale up and working up manufacturing issues so we can conclusion the products at large scale. we have to depend on our colleagues at the national institutes of health and the department of defense to fund that basic research. we don't fund the basic research. and it's very important for us to coordinate our efforts, with them, so as they cultivate products and bring products forward to the earlier stages of dis

dr. richard hatchett. in my testimony today, i will focus on steps taken by the office of the assistant secretary for preparedness and response to strengthen our nation's health security and a contribution to my own office to that end. we have made progress in the past 10 years to advance the state of our national bio defense. committee, and others in congress, we have established barta, and continue to make investments in bio defense and health care. however, as highlighted by recent challenges such as ebola, gaps in, there remain preparedness. as this committee is aware, the recent report by the blue-ribbon study panel on bio defense is indicated that the united states is underprepared for biological threats, and the nation is dangerously vulnerable to biological events. whether natural, intentional, or unintentional in origin. where the civilian public health and medical response is concerned, it is charged by statute to play a strong leadership role. the asper serves as prisoner paul advisor -- princip

dr. hatchett and dr. redd, you can explain how the agencies make use of your research, kind of the sense of where our needs are and what you would like to see? >> sure, sir. thank you for that question. just to be clear, so, i am the acting director of the biomedical development as our name implies we work in the area of research and development. as we understand that term, it means when we're working on medical countermeasures, these are medical countermeasures that have reached the clinical stage of development and many of the problems relate to the clinical testing of the product, as well as to scale up and working up manufacturing issues so we can conclusion the products at large scale. we have to depend on our colleagues at the national institutes of health and the department of defense to fund that basic research. we don't fund the basic research. and it's very important for us to coordinate our efforts, with them, so as they cultivate products and bring products forward to the earlier stages of dis